Main Article Content

Supriati Wila Djami


This article has been retracted at the request of the Editor in Chief of the Indonesian Journal of Medical Laboratoy Science and Technology (IJMLST) volume 1 number 2 of 2019 pages 65-73 with DOI: 10.33086/ijmlst.v1i2.1159 because it has been published in the Journal of Health Information volume 17 number 1 year 2019 pages 64-74 with DOI: 10.31965/infokes.Vol17.Iss1.232.

Papers submitted to IJMLST should neither published previously nor be under consideration for publication another journal. Therefore, the author should make a statement upon submitting. Reusing data in any form must follow good citation principles, therefore this paper has ethical violations in the scientific publishing system.

Notice of the revocation of "N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP) in Stage 1 and Stage 2 Hypertension Patients" in the Indonesian Journal of Medical Laboratoy Science and Technology volume 3 number 1 in 2021.


Download data is not yet available.

Article Details

How to Cite
Djami, S. W. (2019) “RETRACTED: N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE (NT-proBNP) IN STAGE 1 AND STAGE 2 HYPERTENSION PATIENTS”, Indonesian Journal of Medical Laboratory Science and Technology, 1(2), pp. 65–67. doi: 10.33086/ijmlst.v1i2.1159.
NT-proBNP, hypertension, degree of hypertension, duration of hypertension


Rilantono LI. Cardiovascular disease. Jakarta: Faculty of Medicine, University of Indonesia; 2016.

Cardiovascular Specialist Doctors Association of Indonesia (CSDAI). Hypertension Management Guidelines on Cardiovascular Disease. Issue I. Jakarta: Cardiovascular Specialist Doctors Association of Indonesia; 2015.

Joint National Committee (JNC) 8. The Eighth Joint National Committee, Hypertension: The Silent Killer: Update JNC-8 Guideline; 2015.

Muhadi. Evidence-based Guideline. Handling Hypertension Adult Patients, (Online). 2016;43(1).(, Accessed January 14, 2018).

South Sulawesi Provincial Health Office. Health Profile of South Sulawesi Province in 2015. Makassar: South Sulawesi Provincial Health Office; 2015.

Makassar City Health Office. 2015. 2015 Makassar City Health Profile Makassar: Makassar City Health Office.

Hulaima, I.S. 2017. Factors Associated with Control of Blood Pressure in Hypertensive Patients at the Kedaton City Bandar Lampung Health Center. Bandar Lampung: Faculty of Medicine, University of Lampung.

Steffanus M, Wibawa IDN, Nadha IKB. Positive correlation between degree of liver cirrhosis and N terminal-Pro brain natriuretic peptide (NT-pro-BNP).

Khairunnisa. Correlation Levels of NT - proBNP with Left Ventricular Ejection Fraction Function in Children Heart Failure. Padang: Graduate Program in Biomedical Sciences - Medical Specialist Education Program UNAND - RS. M. DJAMIL; 2017.

Bower et al., .N-terminal pro-brain natriuretic peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study.American Journal of Hypertension. 2015;28(10):1262-1266.

Hikmah, N. Relationship between Smoking Time and Hypertension in Rannaloe Village, Bungaya District, Gowa Regency. Makassar. Faculty of Medicine and Health UIN Alauddin; 2017.

Azhar I. Hypertension Patient Characteristics picture in Sleman Gamping Puskesmas Yogyakarta. Yogyakarta: College of Health Sciences of the University General Achmad Yani Yogyakarta; 2017.

Sarzani R. et al . NT-proBNP and Its Correlation Hospital Mortality in the Very Elderly without and Admission Diagnosis of Heart Failue.PLOS Journals.2016;11(4): e0153759.

Munir A,Sargowo N. N Terminal Pro Brain Natriuretic Peptide as Indicator of Left Ventricle Hypertropy In Hypertensive Patients Compared with Left Ventricle Mass Index in Echocardiography. Jurnal Kardiologi Indonesia. 2010;31(2):87-98.

Asterina F, Nasution B, Akbar N. The Level of N Terminal-Pro Brain Natriuretic Peptide in Hypertensive Heart Disease Patients. Indonesian Journal of Clinical Pathology and Medical Laboratory. 2007;14(1):42–46.